Ground News

See every side of every news story

Managed Healthcare Executive image

News from Managed Healthcare Executive

All of today’s top news stories from Managed Healthcare Executive. Get the full analysis behind how media bias impacts breaking news.

We’ve discovered 303 headlines written by Managed Healthcare Executive during the past 3 months.

Managed Healthcare Executive’s media bias is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Managed Healthcare Executive’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Managed Healthcare Executive

Where is Managed Healthcare Executive located?Managed Healthcare Executive's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Managed Healthcare Executive News

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

Royal Bank of Canada · Galway

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

100% Center coverage: 7 sources

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic…See the Story

Massive cuts to Health and Human Services’ workforce signal a dramatic shift in US health policy

Brad Smith · United States

Massive cuts to Health and Human Services’ workforce signal a dramatic shift in US health policy

60% Center coverage: 5 sources

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)See the Story

Costly GLP-1 drug use for weight loss has soared, study reports

Costly GLP-1 drug use for weight loss has soared, study reports

100% Center coverage: 3 sources

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.See the Story

Doctor seeing increased colorectal cancer cases

Doctor seeing increased colorectal cancer cases Radiation oncologist Dr Praveen Sharma is encouraging Jamaicans to screen for colorectal cancer, as it continues to be an increasing cause of death on the island. "Colorectal cancer is one of the third most common cancers in Jamaica, in terms of...See the Story

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

100% Center coverage: 2 sources

New data unveiled Monday showed that Merck’s Winrevair can significantly cut the risk of death, lung transplantation and hospitalization in patients with a rare form of high blood pressure in the lungs, potentially providing a boost to sales.See the Story

Maggie Hassan · Houston

The Impact of Site-Neutral Payment on Healthcare Costs, Patient Access

Connie Estep, Pharm.D., BCGP, director of specialty clinical solutions at Prime Therapeutics, presented on legislative impacts on site of service at this year's AMCP meeting in Houston.See the Story

Apps · England

Mobile App Cuts Skin Cancer Referrals in Half, British Trial Shows

The Map My Mole app provides patients with a small lens attachment for their phones to capture high-quality images of concerning skin spots. These images are then uploaded for assessment by consultants.See the Story

United States · United States

How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy

Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.See the Story

New Study Shows Duchenne's Effect on the Brain Might Be Reversed

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.See the Story

Overcoming Barriers to Treatment in AD

An expert discusses the most common barriers clinicians face when prescribing topical therapies for atopic dermatitis (AD) and their impact on patient adherence as well as strategies dermatologists can employ to navigate insurance coverage, prior authorization and step therapy to ensure patients receive appropriate care.See the Story

CAR-T in Third-Line-Plus LBCL: Treatment Sequencing and Patient Selection

Experts discuss sequencing treatments in the third-line setting or beyond for patients who have not received chimeric antigen receptor T-cell therapy (CAR T) previously, comparing bispecific antibodies, CAR T, and other agents like polatuzumab and tafasitamab, while also considering patient factors and disease characteristics when selecting among available CAR-T options (axicabtagene ciloleucel [axi-cel], lisocabtagene maraleucel [liso-cel], and…See the Story

Breaking News Topics Related to Managed Healthcare Executive

Our use of cookiesCookie policy

Unlike other news sites, we do not share or sell your data to third-parties for targeted ads. In fact, the Ground News application and website do not run any ads at all. Our application and website use cookies and similar technologies to personalize content we deliver to you and also allows us to improve your usage of our platform through analytics. These cookies help us provide the best experience possible. Learn more about cookies and preference selection here.

By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.